Morgan Stanley
WVE icon

Morgan Stanley’s Wave Life Sciences WVE Stock Holding History

Morgan Stanley’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.87M Buy
1,361,001
+951,338
+232% +$12.4M ﹤0.01% 3574
2025
Q4 		$6.96M Sell
409,663
-97,627
-19% -$992K ﹤0.01% 3926
2025
Q3 		$3.71M Sell
507,290
-1,036,748
-67% -$8.39M ﹤0.01% 4376
2025
Q2 		$10M Buy
1,544,038
+364,111
+31% +$2.4M ﹤0.01% 3440
2025
Q1 		$9.53M Buy
1,179,927
+121,541
+11% +$1.33M ﹤0.01% 3379
2024
Q4 		$13.1M Buy
1,058,386
+414,051
+64% +$5.53M ﹤0.01% 3151
2024
Q3 		$5.28M Sell
644,335
-192,679
-23% -$1.15M ﹤0.01% 3918
2024
Q2 		$4.18M Sell
837,014
-108,106
-11% -$617K ﹤0.01% 4029
2024
Q1 		$5.83M Buy
945,120
+564,464
+148% +$2.83M ﹤0.01% 3797
2023
Q4 		$1.92M Buy
380,656
+290,789
+324% +$1.55M ﹤0.01% 4947
2023
Q3 		$517K Sell
89,867
-7,640
-8% -$34.9K ﹤0.01% 5154
2023
Q2 		$355K Sell
97,507
-233,957
-71% -$945K ﹤0.01% 5386
2023
Q1 		$1.44M Buy
331,464
+235,487
+245% +$1.08M ﹤0.01% 4649
2022
Q4 		$672K Buy
95,977
+63,202
+193% +$291K ﹤0.01% 5077
2022
Q3 		$119K Sell
32,775
-49,843
-60% -$165K ﹤0.01% 5992
2022
Q2 		$267K Sell
82,618
-26,887
-25% -$51.7K ﹤0.01% 5749
2022
Q1 		$220K Sell
109,505
-241,466
-69% -$591K ﹤0.01% 5865
2021
Q4 		$1.1M Buy
350,971
+237,337
+209% +$985K ﹤0.01% 4999
2021
Q3 		$557K Sell
113,634
-40,377
-26% -$245K ﹤0.01% 5424
2021
Q2 		$1.03M Sell
154,011
-357,815
-70% -$2.34M ﹤0.01% 5056
2021
Q1 		$2.87M Sell
511,826
-734,547
-59% -$7.06M ﹤0.01% 3968
2020
Q4 		$9.81M Buy
1,246,373
+124,153
+11% +$1.04M ﹤0.01% 2524
2020
Q3 		$9.53M Sell
1,122,220
-26,380
-2% -$289K ﹤0.01% 2074
2020
Q2 		$12M Buy
1,148,600
+462,965
+68% +$4.36M ﹤0.01% 1805
2020
Q1 		$6.42M Buy
685,635
+614,025
+857% +$5.23M ﹤0.01% 2210
2019
Q4 		$575K Buy
71,610
+9,097
+15% +$223K ﹤0.01% 4849
2019
Q3 		$1.28M Buy
62,513
+43,821
+234% +$1M ﹤0.01% 4136
2019
Q2 		$487K Buy
18,692
+10,922
+141% +$306K ﹤0.01% 4620
2019
Q1 		$303K Sell
7,770
-24,137
-76% -$979K ﹤0.01% 4837
2018
Q4 		$1.34M Sell
31,907
-632
-2% -$28.1K ﹤0.01% 4069
2018
Q3 		$1.63M Sell
32,539
-6,323
-16% -$285K ﹤0.01% 4169
2018
Q2 		$1.49M Buy
38,862
+11,946
+44% +$514K ﹤0.01% 4331
2018
Q1 		$1.08M Buy
26,916
+1,178
+5% +$49.5K ﹤0.01% 4494
2017
Q4 		$904K Buy
25,738
+9,371
+57% +$273K ﹤0.01% 4609
2017
Q3 		$355K Buy
16,367
+1,928
+13% +$38.7K ﹤0.01% 5067
2017
Q2 		$268K Buy
14,439
+2,633
+22% +$56.7K ﹤0.01% 5174
2017
Q1 		$325K Sell
11,806
-11,375
-49% -$318K ﹤0.01% 5083
2016
Q4 		$606K Buy
23,181
+20,872
+904% +$679K ﹤0.01% 4803
2016
Q3 		$75K Buy
2,309
+2,301
+28,763% +$54.4K ﹤0.01% 5424
2016
Q2 		$0 Sell
8
-3,819
-100% -$59.5K ﹤0.01% 6667
2016
Q1 		$53K Buy
3,827
+2,770
+262% +$38.7K ﹤0.01% 5589
2015
Q4 		$17K Buy
+1,057
New +$16.6K ﹤0.01% 6089

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley's WVE Position: Q1 2026 in Review

Morgan Stanley increased its Wave Life Sciences (WVE) stake by 232% in Q1 2026, buying an estimated $12.4M and bringing the position to 1,361,001 shares worth $9.87M. The position accounts for ﹤0.01% of the portfolio, ranked #3574.

Morgan Stanley first reported a position in WVE in Q4 2015 and has held it in 42 quarters since. The position peaked at $13.1M in Q4 2024. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Morgan Stanley held 1,361,001 shares of Wave Life Sciences worth $9.87M as of Q1 2026.
  • Morgan Stanley bought 951,338 Wave Life Sciences shares in Q1 2026, an estimated $12.4M.
  • Wave Life Sciences made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3574 holding.
  • Morgan Stanley first reported a position in Wave Life Sciences in Q4 2015 and has held it in 42 quarters since.
  • Morgan Stanley's Wave Life Sciences position peaked at $13.1M in Q4 2024.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.